S.C.R. No. 7 Summary

• Condemns the People's Republic of China for its role as the largest origin point of fentanyl smuggled to the United States and its permissive attitude toward money laundering and drug trafficking within its borders

• Alleges China failed to cooperate with DEA investigations, suspended counternarcotics cooperation with the U.S. in August 2022, and has been slow to allow investigations into illegal chemical production sites

• Documents that Chinese companies like Yuancheng and 5A Pharmatech Co. receive tax incentives including 10% value-added tax rebates on fentanyl and 13% rebates on fentanyl analogues and precursors

• States the Los Zheng cartel operates between China and Mexico with Shanghai-based leaders who remain unarrested by Chinese officials despite maintaining the largest drug trafficking presence in Mexico

• Directs the Senate Clerk to transmit copies of the resolution to Ohio's Congressional delegation, Secretary of State Antony Blinken, and Ohio news media